The Press

Fisher & Paykel Healthcare profit up 86pc


Fisher & Paykel Healthcare, which has benefited from a surge in demand for its breathing aids during the coronaviru­s pandemic, posted an 86 per cent jump in first-half profit and lifted its forecast for the full year. After-tax profit rose to $225.5million in the six months to September 30, from $121.2m last year. Revenue increased 59 per cent to $910.2m. Fisher & Paykel Healthcare has experience­d unpreceden­ted demand for its breathing devices this year as hospitals stocked up on the machines and accessorie­s used to help treat patients with the coronaviru­s. During the half year, demand for its hospital hardware increased, as clinicians increasing­ly used nasal high flow therapy as a frontline treatment for Covid-19 patients.

Newspapers in English

Newspapers from New Zealand